Ten-year-old XNK Therapeutics experiences rapid growing with own GMP facility
XNK Therapeutics has expanded significantly in the past year and now has access to its own GMP-standard production lab.
“We need to have significantly larger capacity to conduct the larger Phase II studies we’re planning. That capacity isn’t available in Sweden, so we’ve built up our own lab in Flemingsberg,” says Johan Liwing, CEO of XNK Therapeutics.
XNK has grown rapidly in recent years and today the company employs almost 30 people in Novum in Flemingsberg. The new GMP facility, with 350sqm of research laboratory space, gives the company better control over its development chain.
Unique technology
XNK Therapeutics was founded in 2012 and is a pioneer in cell therapy. With a unique platform technology, the company focuses primarily on new forms of cancer treatment. The platform enables new cell-based treatments with autologous NK cells.
A clinical investigator-sponsored Phase II study is already being conducted at Karolinska University Hospital, where XNK’s drug candidate is being combined with Sanofi’s anti-CD38 antibody Sarclisa, Isatuximab, for treatment of the severe cancer form multiple myeloma.
“We’re extremely proud of this smaller Phase II study and now we need to increase production capacity. Myeloma is our main focus area, but when we’ve reached the right capacity, there’ll be one or two more [candidates]. It’s important to create a good width outside the blood cancer area,” says Liwing.
XNK Therapeutics is currently conducting a number of projects, including a “proof of concept” study together with the University of Texas MD Anderson Cancer Center in the field of acute myeloid leukemia (AML).
At the beginning of the year, the company raised approximately SEK 130 million in new capital to drive growth.
“It feels great and above all the fact that it’s not only about capital but also provides the addition of competence and production knowledge through NorthX Biologics. We complement each other in a way that enables good synergies,” says Liwing.
“Flemingsberg is the ideal place for us with immediate proximity to everything we need. It’s also home to research in a world-leading research hub and a proximity to a clinic that really knows NK cells.”
Read more about xnktherapeutics.com.
TAKE YOUR IDEA TO THE NEXT LEVEL: Flemingsberg Science Award IDEA 2024 is now open for registration
It’s finally time for the annual competition Flemingsberg Science Award IDEA. The goal is to attract innovators from Flemingsberg, helping them take the step towards realizing their visions while also participating in shaping the businesses of the future. Do you have an idea that can contribute to a better world? Then you should take part in the Flemingsberg Science Award competition.
Welcome to Flemingsberg Pitch Workshop
Together with Venture Cup, one of Sweden's leading platforms for startups and business ideas, Flemingsberg Science Foundation welcomes you to a workshop that will help you create a compelling and engaging pitch to take your startup or idea to the next level. During this highly interactive session Malcolm Larri, coach and pitch expert, will teach you the fundamental building blocks of creating an effective pitch, Venture Cup style. You will also receive feedback on the pitches you create.
Campus day 2024
Campus Day is for all students at Campus Flemingsberg. Come and meet students from Karolinska Institutet, KTH, the Red Cross University College, SMI, and Södertörn University. There will be performances and speeches on stage. Enjoy music, play ping-pong, or take the campus quiz and get a lunch! (Limited availability)
Irma Alert and The Digital Immune System: Winners of the Flemingsberg Science Award STARTUP 2024
Sweden's children and youth are not doing well. Mental health issues, increasing neuropsychiatric disorders, and sociocultural confusion, partly caused by social media, are on the rise. As a result, the level of knowledge among young people is declining, with reading comprehension and mathematics being particularly problematic areas. Irma Alert, the winner of the Flemingsberg Science Award, wants to change this.
Maria Eriksdotter: Dean, Leader and Enthusiast who strengthened the sense of community in Flemingsberg
After her four years as dean, Maria has successfully put KI South and Flemingsberg on the map. Maria is an enthusiast who has driven KI South forward in recent years with great commitment. Now that she is leaving her role as dean of Karolinska Institutet, we at the Flemingsberg Science Foundation reflect on all the progress and achievements she has made.
